116 related articles for article (PubMed ID: 19749354)
1. Influence of 3'-azido-2',3'-dideoxyguanosine treatment on telomere length in human telomerase-immortalized human fibroblast cells.
Kurashina Y; Liu X; Kato C; Inoue N; Saneyoshi M; Yamaguchi T
Nucleic Acids Symp Ser (Oxf); 2009; (53):249-50. PubMed ID: 19749354
[TBL] [Abstract][Full Text] [Related]
2. Influence of 3'-azido-2',3'-dideoxyguanosine treatment on amounts of TERT and POT1 in human HL60 cells.
Liu X; Ogawara T; Kurashina Y; Saneyoshi M; Yamaguchi T
Nucleic Acids Symp Ser (Oxf); 2008; (52):491-2. PubMed ID: 18776468
[TBL] [Abstract][Full Text] [Related]
3. Telomere shortening in human HL60 cells by treatment with 3'-azido-2',3'-dideoxynucleosides and telomerase inhibition by their 5'-triphosphates.
Liu X; Inomata M; Ogawara T; Saneyoshi M; Yamaguchi T
Nucleosides Nucleotides Nucleic Acids; 2007; 26(8-9):1067-71. PubMed ID: 18058538
[TBL] [Abstract][Full Text] [Related]
4. Telomerase inhibition by 3'-azido-2', 3'-dideoxynucleoside 5'-triphosphates and telomere shortening in human cultured cells by the corresponding nucleosides.
Yamaguchi T; Liu X; Ogawara T; Inomata M; Saneyoshi M
Nucleic Acids Symp Ser (Oxf); 2006; (50):271-2. PubMed ID: 17150922
[TBL] [Abstract][Full Text] [Related]
5. 3'-Azido-2',3'-dideoxynucleoside 5'-triphosphates inhibit telomerase activity in vitro, and the corresponding nucleosides cause telomere shortening in human HL60 cells.
Liu X; Takahashi H; Harada Y; Ogawara T; Ogimura Y; Mizushina Y; Saneyoshi M; Yamaguchi T
Nucleic Acids Res; 2007; 35(21):7140-9. PubMed ID: 17942424
[TBL] [Abstract][Full Text] [Related]
6. Influence of nucleoside analogue treatment on telomere length and TRF2 amount in human HL60 cells.
Liu X; Liu J; Ogawara T; Kurashina Y; Yashi R; Saneyoshi M; Yamaguchi T
Nucleic Acids Symp Ser (Oxf); 2007; (51):253-4. PubMed ID: 18029682
[TBL] [Abstract][Full Text] [Related]
7. Resistance to senescence induction and telomere shortening by a G-quadruplex ligand inhibitor of telomerase.
Gomez D; Aouali N; Renaud A; Douarre C; Shin-Ya K; Tazi J; Martinez S; Trentesaux C; Morjani H; Riou JF
Cancer Res; 2003 Oct; 63(19):6149-53. PubMed ID: 14559794
[TBL] [Abstract][Full Text] [Related]
8. Telomere shortening in human HL60 cells by treatment with deoxyguanosine analogs.
Yamaguchi T; Takahashi H; Harada Y; Yoshikawa M; Iyono S; Inomata M; Maruyama T; Saneyoshi M
Nucleic Acids Symp Ser (Oxf); 2004; (48):187-8. PubMed ID: 17150541
[TBL] [Abstract][Full Text] [Related]
9. Effects of telomerase modulation in human hematopoietic progenitor cells.
Zimmermann S; Glaser S; Ketteler R; Waller CF; Klingmüller U; Martens UM
Stem Cells; 2004; 22(5):741-9. PubMed ID: 15342938
[TBL] [Abstract][Full Text] [Related]
10. Gene expression and regulation in H2O2-induced premature senescence of human foreskin fibroblasts expressing or not telomerase.
de Magalhães JP; Chainiaux F; de Longueville F; Mainfroid V; Migeot V; Marcq L; Remacle J; Salmon M; Toussaint O
Exp Gerontol; 2004 Sep; 39(9):1379-89. PubMed ID: 15489061
[TBL] [Abstract][Full Text] [Related]
11. Cyclic induction of senescence with intermittent AZT treatment accelerates both apoptosis and telomere loss.
Ji HJ; Rha SY; Jeung HC; Yang SH; An SW; Chung HC
Breast Cancer Res Treat; 2005 Oct; 93(3):227-36. PubMed ID: 16132531
[TBL] [Abstract][Full Text] [Related]
12. Telomerase inhibition, telomere shortening, cell growth suppression and induction of apoptosis by telomestatin in childhood neuroblastoma cells.
Binz N; Shalaby T; Rivera P; Shin-ya K; Grotzer MA
Eur J Cancer; 2005 Dec; 41(18):2873-81. PubMed ID: 16253503
[TBL] [Abstract][Full Text] [Related]
13. Telomerase inhibition by an siRNA directed against hTERT leads to telomere attrition in HT29 cells.
de Souza Nascimento P; Alves G; Fiedler W
Oncol Rep; 2006 Aug; 16(2):423-8. PubMed ID: 16820926
[TBL] [Abstract][Full Text] [Related]
14. Telomere dynamics in cells with introduced telomerase: a rapid assay for telomerase activity on telomeres.
McChesney PA; Aisner DL; Frank BC; Wright WE; Shay JW
Mol Cell Biol Res Commun; 2000 May; 3(5):312-8. PubMed ID: 10964756
[TBL] [Abstract][Full Text] [Related]
15. Arsenic induces telomerase expression and maintains telomere length in human cord blood cells.
Ferrario D; Collotta A; Carfi M; Bowe G; Vahter M; Hartung T; Gribaldo L
Toxicology; 2009 Jun; 260(1-3):132-41. PubMed ID: 19464579
[TBL] [Abstract][Full Text] [Related]
16. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
Kelland LR
Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
[TBL] [Abstract][Full Text] [Related]
17. Effects of cisplatin on telomerase activity and telomere length in BEL-7404 human hepatoma cells.
Zhang RG; Zhang RP; Wang XW; Xie H
Cell Res; 2002 Mar; 12(1):55-62. PubMed ID: 11942411
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach.
Mo Y; Gan Y; Song S; Johnston J; Xiao X; Wientjes MG; Au JL
Cancer Res; 2003 Feb; 63(3):579-85. PubMed ID: 12566299
[TBL] [Abstract][Full Text] [Related]
19. Telomerase inhibitors in cancer therapy: current status and future directions.
Incles CM; Schultes CM; Neidle S
Curr Opin Investig Drugs; 2003 Jun; 4(6):675-85. PubMed ID: 12901225
[TBL] [Abstract][Full Text] [Related]
20. Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters.
Atkinson SP; Hoare SF; Glasspool RM; Keith WN
Cancer Res; 2005 Sep; 65(17):7585-90. PubMed ID: 16140922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
